Cartography lures Amgen exec to head business development

California, USA-based precision medicine company Cartography Biosciences, which launched in July last year with $57 million financing, has appointed Chester Wong as vice president, head of business development. He also becomes a member of Cartography’s executive leadership team.

In this role, Mr Wong will be responsible for creating key relationships that support the company’s mission and advance its pipeline of next-generation cancer immunotherapies designed around novel cell-specific targets.

Mr Wong joins Cartography from US biotech giant Amgen (Nasdaq: AMGN), where as director of business development he led the execution of several key deals across a wide range of areas including opportunities within oncology, hematology, and immunology. Previously he served on the corporate development team at Onyx Pharmaceuticals, an Amgen subsidiary, and held key roles at Astellas Pharma and Deallus Consulting.